EyePoint, Inc. (EYPT)
2.99
-0.15
(-4.78%)
USD |
NASDAQ |
Oct 16, 16:00
3.09
+0.10
(+3.34%)
After-Hours: 20:00
EyePoint Free Cash Flow (Quarterly) : -63.55M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -63.55M |
| March 31, 2026 | -81.55M |
| December 31, 2025 | -66.03M |
| September 30, 2025 | -60.15M |
| June 30, 2025 | -63.81M |
| March 31, 2025 | -53.40M |
| December 31, 2024 | -36.23M |
| September 30, 2024 | -40.60M |
| June 30, 2024 | -21.08M |
| March 31, 2024 | -32.36M |
| December 31, 2023 | -23.99M |
| September 30, 2023 | -16.92M |
| June 30, 2023 | 56.63M |
| March 31, 2023 | -17.32M |
| December 31, 2022 | -13.17M |
| September 30, 2022 | -14.33M |
| June 30, 2022 | -19.34M |
| March 31, 2022 | -20.31M |
| December 31, 2021 | -16.67M |
| September 30, 2021 | -7.918M |
| June 30, 2021 | -10.57M |
| March 31, 2021 | -15.10M |
| December 31, 2020 | 5.703M |
| September 30, 2020 | 1.008M |
| June 30, 2020 | -5.147M |
| Date | Value |
|---|---|
| March 31, 2020 | -16.36M |
| December 31, 2019 | -11.49M |
| September 30, 2019 | -14.77M |
| June 30, 2019 | -17.13M |
| March 31, 2019 | -13.52M |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| June 30, 2017 | -4.578M |
| March 31, 2017 | -4.559M |
| December 31, 2016 | -5.014M |
| September 30, 2016 | -6.486M |
| June 30, 2016 | -4.393M |
| March 31, 2016 | -4.333M |
| December 31, 2015 | -3.199M |
| September 30, 2015 | -4.504M |
| June 30, 2015 | -3.096M |
| March 31, 2015 | -3.997M |
| December 31, 2014 | 21.23M |
| September 30, 2014 | -4.00M |
| June 30, 2014 | -2.958M |
| March 31, 2014 | -1.906M |
| December 31, 2013 | -2.27M |
| September 30, 2013 | -3.785M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Ocular Therapeutix, Inc. | -70.64M |
| Corcept Therapeutics, Inc. | 31.02M |
| Eli Lilly & Co. | 4.475B |
| Regeneron Pharmaceuticals, Inc. | 521.80M |
| Nuvation Bio, Inc. | -43.22M |